Regulation of apoptosis-related genes by nitric oxide in cancer

Samuel Y Olson1, Hermes J Garbán

  • 1Department of Surgery, Division of Surgical Oncology, David Geffen School of Medicine, University of California, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.

Insights

Nitric oxide (NO) plays a dual role in cancer apoptosis, primarily promoting cell death by upregulating pro-apoptotic genes and downregulating anti-apoptotic genes at the transcriptional level.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Nitric oxide (NO) is a signaling molecule with diverse biological functions.
  • Apoptosis, or programmed cell death, is crucial for normal development and can be dysregulated in cancer.
  • Cancer cells often develop resistance to apoptosis, contributing to tumor survival and progression.

Purpose of the Study:

  • To review the role of nitric oxide (NO) and related species in regulating apoptosis-related genes.
  • To elucidate the transcriptional mechanisms by which NO influences apoptosis in cancer.
  • To discuss the implications of NO-mediated gene regulation in cancer biology and potential therapeutics.

Main Methods:

  • Literature review focusing on transcriptional regulation of apoptosis-related genes by NO.
  • Analysis of signaling pathways transmitting NO effects to the transcriptional machinery.
  • Discussion of functional consequences and therapeutic potential.

Main Results:

  • NO exhibits a dual role in cancer cell apoptosis, either promoting cell death or protecting cells.
  • Evidence suggests NO predominantly promotes pro-apoptotic gene expression and suppresses anti-apoptotic genes.
  • NO-mediated signaling impacts the transcriptional machinery governing apoptosis-related genes.

Conclusions:

  • Nitric oxide significantly influences the expression of apoptosis-related genes at the transcriptional level.
  • NO's role in regulating apoptosis-related genes has critical implications for cancer development and progression.
  • Targeting NO-mediated pathways offers potential therapeutic strategies for cancer treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...